GB1391747A - Antiinflammatory compositions - Google Patents
Antiinflammatory compositionsInfo
- Publication number
- GB1391747A GB1391747A GB4938773A GB4938773A GB1391747A GB 1391747 A GB1391747 A GB 1391747A GB 4938773 A GB4938773 A GB 4938773A GB 4938773 A GB4938773 A GB 4938773A GB 1391747 A GB1391747 A GB 1391747A
- Authority
- GB
- United Kingdom
- Prior art keywords
- tea
- coprecipitate
- oct
- aspirin
- solubilized
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000000203 mixture Substances 0.000 title abstract 3
- 230000003110 anti-inflammatory effect Effects 0.000 title abstract 2
- 235000013616 tea Nutrition 0.000 abstract 6
- 241001122767 Theaceae Species 0.000 abstract 5
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 abstract 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 abstract 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 abstract 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 abstract 2
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 abstract 2
- 239000006071 cream Substances 0.000 abstract 2
- 235000020344 instant tea Nutrition 0.000 abstract 2
- NWUYHJFMYQTDRP-UHFFFAOYSA-N 1,2-bis(ethenyl)benzene;1-ethenyl-2-ethylbenzene;styrene Chemical compound C=CC1=CC=CC=C1.CCC1=CC=CC=C1C=C.C=CC1=CC=CC=C1C=C NWUYHJFMYQTDRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010053155 Epigastric discomfort Diseases 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 abstract 1
- 241000287433 Turdus Species 0.000 abstract 1
- 229960000583 acetic acid Drugs 0.000 abstract 1
- 239000000654 additive Substances 0.000 abstract 1
- 229960001948 caffeine Drugs 0.000 abstract 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 abstract 1
- 239000000969 carrier Substances 0.000 abstract 1
- 239000003729 cation exchange resin Substances 0.000 abstract 1
- 239000000470 constituent Substances 0.000 abstract 1
- 238000001816 cooling Methods 0.000 abstract 1
- 238000000605 extraction Methods 0.000 abstract 1
- 239000012362 glacial acetic acid Substances 0.000 abstract 1
- 229910021645 metal ion Inorganic materials 0.000 abstract 1
- 239000007935 oral tablet Substances 0.000 abstract 1
- 230000003647 oxidation Effects 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 229910000029 sodium carbonate Inorganic materials 0.000 abstract 1
- 235000014620 theaflavin Nutrition 0.000 abstract 1
- 235000008118 thearubigins Nutrition 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/82—Theaceae (Tea family), e.g. camellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/148—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with compounds of unknown constitution, e.g. material from plants or animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Botany (AREA)
- Pain & Pain Management (AREA)
- Alternative & Traditional Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Rheumatology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Tea And Coffee (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US30079672A | 1972-10-25 | 1972-10-25 | |
| US40494573A | 1973-10-10 | 1973-10-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1391747A true GB1391747A (en) | 1975-04-23 |
Family
ID=26971986
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4938773A Expired GB1391747A (en) | 1972-10-25 | 1973-10-23 | Antiinflammatory compositions |
Country Status (18)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8246943B2 (en) | 2009-05-19 | 2012-08-21 | Conopco, Inc. | Prebiotic composition |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS54122259A (en) * | 1978-03-13 | 1979-09-21 | Kyowa Hakko Kogyo Co Ltd | Aluminum acetylsalicylate glutaminate |
| DE3603576A1 (de) * | 1986-02-06 | 1987-08-13 | Code Kaffee Handel | Verwendung von gerbstoffen und/oder chlorogensaeure sowie nahrungs-, genuss- und/oder arzneimittel mit gerbstoff- und/oder chlorogensaeurezusatz |
| DE102006004912A1 (de) | 2006-01-20 | 2007-07-26 | Rheinmetall Waffe Munition Gmbh | System zum Schutz insbesondere großer fliegender Plattformen vor infrarot- bzw. radargelenkter Bedrohungen |
| DE102014200045A1 (de) * | 2014-01-07 | 2015-07-09 | Ralph Nussbaum | Polyphenol-Konjugate |
| JP6367623B2 (ja) * | 2014-07-04 | 2018-08-01 | 美紀 坂巻 | 水棲原虫駆除剤およびその製造方法 |
-
1970
- 1970-10-29 IL IL43512A patent/IL43512A0/xx unknown
-
1973
- 1973-10-15 CA CA183,398A patent/CA1018459A/en not_active Expired
- 1973-10-18 IE IE1867/73A patent/IE40139B1/xx unknown
- 1973-10-20 IN IN2335/CAL/73A patent/IN139752B/en unknown
- 1973-10-23 PH PH15143A patent/PH12248A/en unknown
- 1973-10-23 SE SE7314372A patent/SE423487B/xx unknown
- 1973-10-23 FR FR7337765A patent/FR2204415B1/fr not_active Expired
- 1973-10-23 NL NLAANVRAGE7314546,A patent/NL176142C/xx not_active IP Right Cessation
- 1973-10-23 DE DE2353087A patent/DE2353087C2/de not_active Expired
- 1973-10-23 BE BE136957A patent/BE806392A/xx not_active IP Right Cessation
- 1973-10-23 GB GB4938773A patent/GB1391747A/en not_active Expired
- 1973-10-23 NO NO734097A patent/NO140748C/no unknown
- 1973-10-24 DK DK576473AA patent/DK134096B/da unknown
- 1973-10-24 AR AR250676A patent/AR199592A1/es active
- 1973-10-24 ES ES419913A patent/ES419913A1/es not_active Expired
- 1973-10-24 CH CH1498073A patent/CH604721A5/xx not_active IP Right Cessation
- 1973-10-24 FI FI733303A patent/FI51428C/fi active
- 1973-10-25 JP JP48119475A patent/JPS5933563B2/ja not_active Expired
- 1973-10-29 IL IL43512A patent/IL43512A/en unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8246943B2 (en) | 2009-05-19 | 2012-08-21 | Conopco, Inc. | Prebiotic composition |
Also Published As
| Publication number | Publication date |
|---|---|
| DE2353087A1 (de) | 1974-05-09 |
| IE40139B1 (en) | 1979-03-28 |
| JPS4993519A (enrdf_load_html_response) | 1974-09-05 |
| AR199592A1 (es) | 1974-09-13 |
| IL43512A0 (en) | 1974-03-14 |
| FI51428B (enrdf_load_html_response) | 1976-09-30 |
| IL43512A (en) | 1976-08-31 |
| CH604721A5 (enrdf_load_html_response) | 1978-09-15 |
| NL176142B (nl) | 1984-10-01 |
| FR2204415B1 (enrdf_load_html_response) | 1976-09-03 |
| DE2353087C2 (de) | 1984-04-26 |
| JPS5933563B2 (ja) | 1984-08-16 |
| CA1018459A (en) | 1977-10-04 |
| DK134096B (da) | 1976-09-13 |
| AU6172573A (en) | 1975-04-24 |
| NL176142C (nl) | 1985-03-01 |
| FI51428C (fi) | 1977-01-10 |
| NO140748B (no) | 1979-07-30 |
| NO140748C (no) | 1979-11-07 |
| DK134096C (enrdf_load_html_response) | 1977-02-14 |
| NL7314546A (enrdf_load_html_response) | 1974-04-29 |
| IE40139L (en) | 1974-04-25 |
| IN139752B (enrdf_load_html_response) | 1976-07-24 |
| BE806392A (fr) | 1974-02-15 |
| SE423487B (sv) | 1982-05-10 |
| ES419913A1 (es) | 1976-09-01 |
| PH12248A (en) | 1978-12-12 |
| FR2204415A1 (enrdf_load_html_response) | 1974-05-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IE35283L (en) | Substiuted benzylimidazolidinones | |
| GB1376096A (en) | 1-3,4-methylenedioxy-phenyl-4,4-dimethyl-1-pentene derivatives | |
| GB1391747A (en) | Antiinflammatory compositions | |
| JPS57134482A (en) | 1-ethyl-6-fluoro-1,4-dihydro-4-oxo-7-(1-piperazinyl)-1,8- naphthyridine-3-carboxylic acid-3/2 hydrate and its preparation | |
| GB1426483A (en) | Vincamine derivatives and process for the preparation of vincamine and derivatives thereof | |
| IE42979L (en) | Pyrazinyl piperazine derivatives | |
| GB1428945A (en) | Sweetening compositions | |
| GB1207771A (en) | Anti-virally active quinoline derivatives | |
| GB1428110A (en) | Pharmaceutical antihypertensive and vasodilator compositions | |
| GB1446584A (en) | Agent for deodorising and influencing perspiration | |
| ES427653A1 (es) | Procedimiento para la preparacion de nuevos acidos 3-hidro- xiacilaminometil-5-acilamino-2, 4, 6-triyodo-benzoicos. | |
| CA984849A (en) | Metal complexes of n,n'-dialkylesters of ethylenedinitrilotetraacetic acid and compositions stabilized thereby | |
| GB1357813A (en) | Effervescent composition for the treatment of heart diseases | |
| JPS5210226A (en) | Process for preparation of aromatic hydroxy compound | |
| GB1424611A (en) | Pharmaceutical compositions | |
| GB1268188A (en) | N-hydroxyalkyl-2,4,6-triiodosuccinanilic acids and their use as x-ray contrast agents | |
| ES411993A1 (es) | Un procedimiento de preparacion de derivados de ceto-acidosaromaticos. | |
| GB1261660A (en) | alpha-HYDRAZINO ACIDS | |
| GB1381072A (en) | 3-amino-as-triazino-6,5-quinoline and derivatives | |
| IE33581B1 (en) | Method of treatment and pharmaceutical preparation | |
| GB1356489A (en) | Compositions for and method of combating coccidiosis and mareks disease in poultry | |
| GB1440673A (en) | Preparation of mixed cobaltous and manganous acetates | |
| GB894752A (en) | Improvements in or relating to citric acid derivatives | |
| ES337292A1 (es) | Procedimiento de preparacion del acido 6,7-dihidroxi cuma- rina 4-metilsulfonico y de sus sales. | |
| GB1263206A (en) | Complexes and salts of magnesium with orotic acid and amino acids |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PCNP | Patent ceased through non-payment of renewal fee |